Biotechnology in the Development of New Vaccines and Diagnostic Reagents Against Tuberculosis

E-ISSN： 1873-4316|2|2|157-173

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.2, Iss.2, 2001-06, pp. : 157-173

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Hunt for New Tuberculosis Vaccines: Anti-TB Immunity and Rational Design of Vaccines

Current Pharmaceutical Design, Vol. 7, Iss. 11, 2001-07 ,pp. : 1015-1037

Bentham Science Publishers

Access to resources Recommend Favorite

New Tuberculosis Drugs in Development

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 5, 2007-03 ,pp. : 463-473

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in the development of vaccines against Marburg and Ebola viruses

By Collins Peter L Bukreyev Alexander

Future Virology, Vol. 2, Iss. 6, 2007-11 ,pp. : 537-541

Future Medicine

Access to resources Recommend Favorite

The Methylerythritol Phosphate (MEP) Pathway for Isoprenoid Biosynthesis as a Target for the Development of New Drugs Against Tuberculosis

Current Medicinal Chemistry, Vol. 18, Iss. 9, 2011-03 ,pp. : 1325-1338

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in the Development of Adenovirus- and Poxvirus- Vectored Tuberculosis Vaccines

Current Gene Therapy, Vol. 5, Iss. 5, 2005-10 ,pp. : 485-492

Bentham Science Publishers

Access to resources Recommend Favorite